REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc., listed under ticker PAIC, filed a Form S-1/A amended registration statement with the U.S. Securities and Exchange Commission on January 29, 2024. The clinical-stage biopharmaceutical company is focused on developing therapeutics in the immune health and infectious disease space, placing it squarely within the healthcare and life sciences sector. The S-1/A updates previously filed registration disclosures as the company continues its obligations as a public reporting issuer. SpacDesk tracks filings, deal histories, and company profiles for SPAC-linked entities across all major sectors; sign up for a SpacDesk account to access the full data record for PAIC and the broader SPAC universe.